GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links.

Trinity E3 2003 Preshow Report

Gray Matter's futuristic first-person action game focusing on the deeds of a scientifically enhanced vigilante will make its public debut at E3.

Comments

Activision will be unveiling Trinity, a new futuristic first-person action game, at E3. The game is set in New Orleans in the year 2013, when a virulent plague is sweeping across the city. New Orleans' only hope to stop the virus from spreading further is the Nightstalker. This biotechnically enhanced vigilante possesses superhuman powers and must single-handedly take action against an evil company known as the Silmara Corporation.

As the Nightstalker, you'll follow a story of conspiratorial intrigue. You'll get some help from the Caretaker, who you'll be able to talk to directly through a brain implant. The Nightstalker has had his abilities enhanced by an array of biotechnical and neurological implants that grant him superhuman strength, special vision powers, and the ability to warp time and space--a power known as Flash. Flashtime will allow you to slow down time to dodge enemies or execute special attacks. Flash can also be used to jump higher, move enormous objects, and survive falls from great heights. Special thermal-vision and night-vision modes will give you the chance to get the drop on enemies.

A potent arsenal is the key to your survival as you face down Silmara. You'll have a range of small arms to choose from, including machine guns, shotguns, sniper rifles, and grenade launchers, plus the more futuristic laser rifles and liquid nitrogen cannons. As a change of pace, you'll man turrets, ride gunships, hack into installations, and solve a variety of puzzles. Trinity is being developed at Gray Matter, the creators of Return to Castle Wolfenstein, and it is scheduled for release in 2004.

Got a news tip or want to contact us directly? Email news@gamespot.com

Join the conversation
There are no comments about this story